Advertisment

Redefining Liver Cancer Risk: The Significant Role of Viscoelasticity

author-image
Dr. Jessica Nelson
New Update
NULL

Redefining Liver Cancer Risk: The Significant Role of Viscoelasticity

Advertisment

Historically, liver cancer has been primarily associated with matrix stiffness; however, a groundbreaking study published in Nature by researchers at Stanford University challenges this long-standing belief. The research unveils the critical role of viscoelasticity in liver cancer progression, especially in individuals with Type 2 Diabetes. This revelation could revolutionize the way liver cancer is screened, potentially facilitating earlier detection and intervention, thereby saving lives.

Advertisment

The Role of Viscoelasticity in Liver Cancer

Viscoelasticity refers to the property of materials that exhibit both viscous and elastic characteristics when undergoing deformation. In the context of liver cancer, viscoelasticity is shown to have a significant impact on the disease's progression, particularly in the pre-cirrhotic liver. The study found that changes in the structure of the extracellular matrix (ECM), especially increased viscoelasticity, can trigger the induction and growth of hepatocellular carcinoma (HCC), the most common type of liver cancer.

The research also found that Advanced Glycation End Products (AGEs) promote changes in collagen architecture, enhancing ECM viscoelasticity. This leads to faster stress relaxation and viscous dissipation, conditions conducive to cancer development. Enhanced viscoelasticity was found to promote HCC cell proliferation and invasion through an integrin β1 tensin 1 YAP mechanotransductive pathway, further emphasizing the role of viscoelasticity in liver cancer progression.

Advertisment

Implications for People with Type 2 Diabetes

The study shows that viscoelasticity is more closely correlated with liver cancer, especially in people with Type 2 diabetes, as they are at a higher risk. A significant number of patients with Type 2 diabetes were found to have higher levels of AGEs compared to people without the condition. The research also showed that their viscoelasticity was higher, although their liver was not as hard. This suggests that liver viscoelasticity, rather than stiffness, could be a more accurate predictor of liver cancer in people with Type 2 diabetes.

Importance of Early Detection and Intervention

Advertisment

The findings from this research underscore the importance of early detection and intervention in managing liver cancer. By understanding the role of viscoelasticity in liver cancer progression, medical professionals can potentially identify the disease in its early stages, leading to a more effective treatment. Non-invasive assessment of viscoelasticity is possible with MR elastography, a technique that could aid in early detection. Furthermore, the research highlights the potential benefits of GLP-1 agonists, a class of drugs used to treat Type 2 diabetes, in lowering the risk of developing cirrhosis and liver cancer in patients with Type 2 diabetes and chronic liver disease.

Conclusion: A Paradigm Shift in Understanding Liver Cancer Risk

This groundbreaking study paves the way for a paradigm shift in understanding the risk of liver cancer. It emphasizes the role of viscoelasticity, particularly in people with Type 2 diabetes, challenging the prevalent belief that liver stiffness is the primary predictor. This novel understanding could lead to better screening methods, earlier detection, and potentially more effective interventions for liver cancer. Supported by Stanford Medicine's SPARK Program in Translational Research and its Innovative Medicines Accelerator, this research also received funding from the National Institutes of Health and other institutions, reaffirming the importance of ongoing studies in this field.

Advertisment
Chat with Dr. Medriva !